ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
솔리리스 시장 규모는 향후 몇 년간 강한 성장세를 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 보완인자 매개 질환의 유병률 증가, 유전자 치료 기술의 발전, 신흥 지역에서의 시장 접근성 확대, 바이오시밀러의 확장, 환자 순응도 개선 등에 기인할 것으로 분석됩니다. 예측 기간의 주요 동향으로는 복합 요법의 채택, 환자 중심 치료의 증가, 맞춤형 의약품으로의 전환, 디지털 건강 기술의 사용 증가, 비용 효율성 및 가치 기반 치료에 대한 집중 등이 있습니다.
희귀 혈액 질환의 유병률이 증가함에 따라 솔리리스 시장의 성장이 가속화될 것으로 예상됩니다. 혈우병, 겸상 적혈구 빈혈, 지중해 빈혈과 같은 희귀 혈액 질환은 혈액 생성, 성분 또는 응고에 영향을 미치는 질환입니다. 이러한 질환의 증가는 진단 기술의 발전, 인식의 제고, 유전적 및 환경적 요인에 기인합니다. 솔리리스(에쿨리주맙)는 보체 단백질 C5를 억제하여 보체 과잉 활성화를 방지함으로써 이러한 질환을 관리하고, 용혈 및 장기 손상과 같은 심각한 합병증의 위험을 줄입니다. 영국 국민건강보험(NHS England)에 따르면, 약 1만 7,000명의 사람들이 겸상적혈구 질환을 앓고 있으며, 매년 250건의 새로운 사례가 진단되고 있습니다. 이러한 유병률의 증가는 솔리리스에 대한 수요를 촉진하고 있습니다.
희귀 질환 연구에 대한 투자가 증가하면서 솔리리스 시장이 활기를 띠고 있습니다. 유전학 분야의 발전과 충족되지 않은 의료 요구의 인식으로 희귀 질환 연구에 대한 투자가 증가하면서 솔리리스로 치료할 수 있는 질환에 대한 이해가 확대되고 있습니다. 이는 효과적인 치료법 수요 증가로 이어집니다. 예를 들어, 2023년 7월 영국 정부는 생물의학 연구 센터에 8억 3,420만 달러, UK Rare Disease Research Platform에 1,506만 달러를 투자했습니다. 이 투자는 희귀 질환의 진단 및 치료 개발을 강화해 솔리리스 시장 성장을 더욱 촉진할 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 솔리리스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 솔리리스 시장 : 성장률 분석
세계의 솔리리스 시장 실적 : 규모와 성장(2019-2024년)
세계의 솔리리스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 솔리리스 : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 솔리리스 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈장 교환
혈장 주입
세계의 솔리리스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
발작성 야간 혈색소뇨증(PNH)
비전형 용혈성 요독 증후군(AHUS)
세계의 솔리리스 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 솔리리스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 솔리리스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
솔리리스 시장 : 경쟁 구도
솔리리스 시장 : 기업 프로파일
Pfizer
SLR
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
솔리리스 시장(2029년) : 새로운 기회를 제공하는 국가
솔리리스 시장(2029년) : 새로운 기회를 제공하는 부문
솔리리스 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Soliris (eculizumab) is a monoclonal antibody developed by Alexion Pharmaceuticals. It works by inhibiting the complement protein C5, thereby reducing inflammation and damage caused by an overactive immune system. Soliris is primarily used to treat rare diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG).
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of soliris are plasma exchange and plasma infusion. Plasma exchange is a medical procedure in which a patient's plasma is removed and replaced to treat various conditions, including autoimmune or blood disorders. It is used for treating conditions like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The soliris market research report is one of a series of new reports from The Business Research Company that provides soliris market statistics, including the soliris industry's global market size, regional shares, competitors with a soliris market share, detailed Soliris market segments, market trends and opportunities, and any further data you may need to thrive in the soliris industry. This soliris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The soliris market size is expected to see strong growth in the next few years. It will grow to $3,734.9 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to the increasing prevalence of complement-mediated diseases, advancements in gene therapy, growing market access in emerging regions, expansion of biosimilars, and improved patient compliance. Major trends in the forecast period include the adoption of combination therapies, rise in patient-centric treatments, shift towards personalized medicine, growing use of digital health technologies, and focus on cost-effectiveness and value-based care.
The increasing prevalence of rare blood disorders is expected to propel the growth of the soliris market. Rare blood disorders, such as hemophilia, sickle cell anemia, and thalassemia, are conditions that affect blood production, components, or clotting. The rise in these disorders is attributed to improved diagnostic techniques, greater awareness, and genetic and environmental factors. Soliris (eculizumab) helps manage these conditions by inhibiting the complement protein C5, which prevents excessive complement activation, reducing the risk of severe complications like hemolysis and organ damage. According to NHS England, approximately 17,000 people are living with sickle cell disease, with 250 new cases diagnosed annually. This increasing prevalence is driving the demand for soliris.
The growing investment in rare disease research is fueling the soliris market. With advancements in genomics and the recognition of unmet medical needs, there is increased investment in rare disease research, which helps expand the understanding of conditions treated by Soliris. This leads to a rise in demand for effective treatments. For instance, in July 2023, the UK government invested significant funds, including USD 834.20 million for Biomedical Research Centers and USD 15.06 million for the UK Rare Disease Research Platform. This investment aims to enhance diagnostic and treatment development for rare diseases, further promoting the growth of the Soliris market.
A key trend in the soliris market is the development of biologic medicines for treating neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that affects the central nervous system. This development improves treatment options for rare blood disorders. In October 2023, AstraZeneca received approval for Soliris from China's National Medical Products Administration (NMPA) for the treatment of adult NMOSD patients who are positive for anti-aquaporin-4 (AQP4) antibodies. Soliris is the first and only complement inhibitor approved for NMOSD treatment in China, marking a significant advancement in managing this debilitating condition.
The Key player operating in the soliris market is Pfizer
North America was the largest region in the Soliris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in soliris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the soliris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The soliris market consists of sales of soliris (eculizumab) 300 mg/30 mL vial, soliris (eculizumab) injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Soliris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on soliris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for soliris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The soliris market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Plasma Exchange; Plasma Infusion
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Soliris Market Characteristics
3. Soliris Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Soliris Market Trends And Strategies
5. Soliris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Soliris Growth Analysis And Strategic Analysis Framework
6.1. Global Soliris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Soliris Market Growth Rate Analysis
6.4. Global Soliris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Soliris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Soliris Total Addressable Market (TAM)
7. Global Soliris Market Pricing Analysis & Forecasts
8. Soliris Market Segmentation
8.1. Global Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plasma Exchange
Plasma Infusion
8.2. Global Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Atypical Hemolytic Uremic Syndrome (AHUS)
8.3. Global Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
9. Global Soliris Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Soliris Market Regional And Country Analysis
10.1. Global Soliris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Soliris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Soliris Market
11.1. Asia-Pacific Soliris Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Soliris Market
12.1. China Soliris Market Overview
12.2. China Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Soliris Market
13.1. India Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Soliris Market
14.1. Japan Soliris Market Overview
14.2. Japan Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Soliris Market
15.1. Australia Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Soliris Market
16.1. South Korea Soliris Market Overview
16.2. South Korea Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Soliris Market
17.1. Western Europe Soliris Market Overview
17.2. Western Europe Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Soliris Market
18.1. UK Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Soliris Market
19.1. Germany Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Soliris Market
20.1. France Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Soliris Market
21.1. Eastern Europe Soliris Market Overview
21.2. Eastern Europe Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Soliris Market
22.1. North America Soliris Market Overview
22.2. North America Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Soliris Market
23.1. USA Soliris Market Overview
23.2. USA Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Soliris Market
24.1. Canada Soliris Market Overview
24.2. Canada Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Soliris Market
25.1. South America Soliris Market Overview
25.2. South America Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Soliris Market
26.1. Middle East Soliris Market Overview
26.2. Middle East Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Soliris Market
27.1. Africa Soliris Market Overview
27.2. Africa Soliris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Soliris Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Soliris Market Competitive Landscape And Company Profiles
28.1. Soliris Market Competitive Landscape
28.2. Soliris Market Company Profiles
28.2.1. Pfizer Overview, Products and Services, Strategy and Financial Analysis
28.2.2. SLR Overview, Products and Services, Strategy and Financial Analysis
29. Global Soliris Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Soliris Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Soliris Market
32. Recent Developments In The Soliris Market
33. Soliris Market High Potential Countries, Segments and Strategies
33.1 Soliris Market In 2029 - Countries Offering Most New Opportunities
33.2 Soliris Market In 2029 - Segments Offering Most New Opportunities
